Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Dhar, K. Desai, G. Bignardi (Sunderland, United Kingdom). Can procalcitonin testing reduce antibiotic prescribing for respiratory infections?. Eur Respir J 2006; 28: Suppl. 50, 4656

Member's Comments

No comment yet.

Related content which might interest you: Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection Source: Eur Respir J 2011; 37: 119-125 Year: 2011 Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection Source: Eur Respir J 2010; 36: 601-607 Year: 2010 Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines Source: Eur Respir J 2011; 37: 112-118 Year: 2011 Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Source: Eur Respir J 2007; 30: 556-573 Year: 2007 Current treatments for respiratory infections in children Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children Year: 2005 The role of Chlamydiae spp. in respiratory infections Source: Annual Congress 2005 - Difficult infections in the respiratory patient Year: 2005 The use of C-reactive protein reduces antibiotic prescription for lower respiratory tract infections in primary care Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010 Impact of appropriate diagnostics on the management of respiratory tract infections Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 Are antimicrobials still the future of respiratory infection therapy? Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Interventions to reduce antibiotic prescription for lower respiratory tract infections: Happy Audit study Source: Eur Respir J 2012; 40: 436-441 Year: 2012 The role of procalcitonin in the differential diagnosis and in the response to treatment of lower respiratory tract infections Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Lower respiratory tract infections: when are antibiotics mandatory? Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146 Year: 2004 Antibiotics in acute exacerbations: what do we need? Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Age-related pattern of childhood lung infection and its complications Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=189 Year: 2002 Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis Source: Eur Respir J 2003; 21: 939-943 Year: 2003 Treatment of community-acquired lower respiratory tract infections in adults Source: Eur Respir J 2002; 20: 40S-53S Year: 2002 Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children? Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008 Intrapulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=13 Year: 2004 Reducing inappropriate antibiotic use in lower respiratory tract infection (LRTI); a quality improvement study Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013